Effectiveness and impact of nirsevimab in Chile during the first season of a national immunisation strategy against RSV (NIRSE-CL): a retrospective observational study [0.03%]
一项关于首个全国性RSV免疫策略期间nirsevimab在智利的有效性和影响的回顾性观察研究(NIRSE-CL)
Juan Pablo Torres,Denis Sauré,Marcel Goic et al.
Juan Pablo Torres et al.
Background: Nirsevimab for the prevention of respiratory syncytial virus (RSV) was introduced in some countries in the northern hemisphere in 2023. Chile was the first to implement a universal strategy in the southern hem...
RSV prevention: public health lessons from the southern hemisphere [0.03%]
南方国家的公共卫生经验对预防呼吸道合胞病毒(RSV)有何启示?
Narmeen Mallah,Federico Martinón-Torres
Narmeen Mallah
Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial [0.03%]
在孟加拉国婴儿中,减量灭活脊髓灰质炎疫苗与全剂量灭活脊髓灰质炎疫苗的安全性和免疫原性比较:一项双盲非劣效性随机对照III期试验
Prasad S Kulkarni,Khalequ Zaman,Sajjad A Desai et al.
Prasad S Kulkarni et al.
Background: Replacing oral polio vaccines with inactivated polio vaccines (IPVs) is necessary to stop the potential transmission of vaccine-derived polio viruses. We aimed to compare the safety and immunogenicity of a dos...
Keiya Uriu,Kaho Okumura,Yoshifumi Uwamino et al.
Keiya Uriu et al.
Antigenic and virological characteristics of SARS-CoV-2 variants BA.3.2, XFG, and NB.1.8.1 [0.03%]
SARS-CoV-2变异株BA.3.2、XFG和NB.1.8.1的抗原性和病毒学特征分析
Caiwan Guo,Yuanling Yu,Jingyi Liu et al.
Caiwan Guo et al.
Haemophagocytic lymphohistiocytosis (HLH) secondary to measles in an adult with a loss of post-vaccination humoral immunity following rituximab [0.03%]
利妥昔单抗治疗后接种疫苗的体液免疫丧失成人患者继发麻疹引起的噬血细胞性淋巴组织细胞增生症(HLH)
Alp Aslan Notghi,Joseph Delahunty,Rachel S Tattersall et al.
Alp Aslan Notghi et al.
Measles is an important re-emergent infectious disease globally. Vaccine immunity at the population level is key to the prevention of outbreaks, as unvaccinated or immunosuppressed adults are particularly vulnerable to severe infection. Wit...
Neuroinvasive Oropouche virus in a patient with HIV from extra-Amazonian Brazil [0.03%]
一名HIV阳性患者感染了非亚马逊地区的Oropouche病毒重症脑炎病例报告
Felipe Donateli Gatti,Joana Zorzal Nodari,Thiago de Jesus Sousa et al.
Felipe Donateli Gatti et al.
Long-term effects of azithromycin mass administration to reduce childhood mortality on Streptococcus pneumoniae antimicrobial resistance: a population-based, cross-sectional, follow-up carriage survey [0.03%]
阿奇霉素群体给药减少儿童死亡对肺炎链球菌抗微生物耐药性的长期影响:基于人口的、横断面的、随访携带调查研究
Akuzike Kalizangoma,Jia Mun Chan,Khumbo Kalua et al.
Akuzike Kalizangoma et al.
Background: Mass drug administration (MDA) programmes with the macrolide antibiotic azithromycin to reduce childhood mortality are expanding in Africa; however, concerns remain about the long-term effects of these program...
The (Re)-emerging And ePidemic Infectious Diseases (RAPID) Stigma Scales: a cross-outbreak scale development and pyschometric validation study [0.03%]
传染病复发和流行(快速)耻辱量表:横断疫情量表开发与心理测量学验证研究
Amy Paterson,Kondwani K Mughogho,Ashleigh Cheyne et al.
Amy Paterson et al.
Reducing stigma during infectious disease outbreaks is crucial for delivering an effective response. However, no validated stigma scales exist for use across outbreaks, and outbreak-specific scales are developed too slowly to guide timely i...
Sandro Vento
Sandro Vento